243 related articles for article (PubMed ID: 34965490)
1. Genetic architecture of motor neuron diseases.
Chaudhary R; Agarwal V; Rehman M; Kaushik AS; Mishra V
J Neurol Sci; 2022 Mar; 434():120099. PubMed ID: 34965490
[TBL] [Abstract][Full Text] [Related]
2. Exploring Motor Neuron Diseases Using iPSC Platforms.
Johns AE; Maragakis NJ
Stem Cells; 2022 Mar; 40(1):2-13. PubMed ID: 35511862
[TBL] [Abstract][Full Text] [Related]
3. Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
Winner B; Marchetto MC; Winkler J; Gage FH
Hum Mol Genet; 2014 Sep; 23(R1):R27-34. PubMed ID: 24821704
[TBL] [Abstract][Full Text] [Related]
4. [Motor neuron diseases : Clinical and genetic differential diagnostics].
Regensburger M; Weidner N; Kohl Z
Nervenarzt; 2018 Jun; 89(6):658-665. PubMed ID: 29767817
[TBL] [Abstract][Full Text] [Related]
5. RNA dysregulation in diseases of motor neurons.
Ibrahim F; Nakaya T; Mourelatos Z
Annu Rev Pathol; 2012; 7():323-52. PubMed ID: 22035195
[TBL] [Abstract][Full Text] [Related]
6. Autophagy in motor neuron diseases.
Rodríguez-Muela N
Prog Mol Biol Transl Sci; 2020; 172():157-202. PubMed ID: 32620242
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.
Sprute R; Jergas H; Ölmez A; Alawbathani S; Karasoy H; Dafsari HS; Becker K; Daimagüler HS; Nürnberg P; Muntoni F; Topaloglu H; Uyanik G; Cirak S
Am J Med Genet A; 2021 Feb; 185(2):344-354. PubMed ID: 33155358
[TBL] [Abstract][Full Text] [Related]
8. Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade.
Cantara S; Simoncelli G; Ricci C
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732027
[TBL] [Abstract][Full Text] [Related]
9. Fishing for causes and cures of motor neuron disorders.
Patten SA; Armstrong GA; Lissouba A; Kabashi E; Parker JA; Drapeau P
Dis Model Mech; 2014 Jul; 7(7):799-809. PubMed ID: 24973750
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish models of human motor neuron diseases: advantages and limitations.
Babin PJ; Goizet C; Raldúa D
Prog Neurobiol; 2014 Jul; 118():36-58. PubMed ID: 24705136
[TBL] [Abstract][Full Text] [Related]
11. Hereditary spastic paraplegia: More than an upper motor neuron disease.
Parodi L; Fenu S; Stevanin G; Durr A
Rev Neurol (Paris); 2017 May; 173(5):352-360. PubMed ID: 28449883
[TBL] [Abstract][Full Text] [Related]
12. The genetics of motor neuron diseases.
Figlewicz DA; Orrell RW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Dec; 4(4):225-31. PubMed ID: 14753656
[TBL] [Abstract][Full Text] [Related]
13. Genetics of motor neuron disorders: new insights into pathogenic mechanisms.
Dion PA; Daoud H; Rouleau GA
Nat Rev Genet; 2009 Nov; 10(11):769-82. PubMed ID: 19823194
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.
Malacarne C; Galbiati M; Giagnorio E; Cavalcante P; Salerno F; Andreetta F; Cagnoli C; Taiana M; Nizzardo M; Corti S; Pensato V; Venerando A; Gellera C; Fenu S; Pareyson D; Masson R; Maggi L; Dalla Bella E; Lauria G; Mantegazza R; Bernasconi P; Poletti A; Bonanno S; Marcuzzo S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073630
[TBL] [Abstract][Full Text] [Related]
15.
Penttilä S; Jokela M; Saukkonen AM; Toivanen J; Palmio J; Lähdesmäki J; Sandell S; Shcherbii M; Auranen M; Ylikallio E; Tyynismaa H; Udd B
J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):272-277. PubMed ID: 27810918
[No Abstract] [Full Text] [Related]
16. Genetic determination of motor neuron disease and neuropathy.
Vrebalov Cindro P; Vrebalov Cindro V
Coll Antropol; 2015 Mar; 39(1):261-5. PubMed ID: 26040103
[TBL] [Abstract][Full Text] [Related]
17. Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort.
Scarlino S; Domi T; Pozzi L; Romano A; Pipitone GB; Falzone YM; Mosca L; Penco S; Lunetta C; Sansone V; Tremolizzo L; Fazio R; Agosta F; Filippi M; Carrera P; Riva N; Quattrini A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397312
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
O'Connor DM; Boulis NM
Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
[TBL] [Abstract][Full Text] [Related]
19. Histone acetylation as a potential therapeutic target in motor neuron degenerative diseases.
Garbes L; Riessland M; Wirth B
Curr Pharm Des; 2013; 19(28):5093-104. PubMed ID: 23448465
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
Bowerman M; Murray LM; Scamps F; Schneider BL; Kothary R; Raoul C
Eur J Med Genet; 2018 Nov; 61(11):685-698. PubMed ID: 29313812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
